Treatment of partial prostate
Showing 1 - 25 of 9,361
Prostate Adenocarcinoma, Prostate Cancer Trial (Transvesical Single Port Robotic Partial Prostatectomy, High-intensity focused
Not yet recruiting
- Prostate Adenocarcinoma
- Prostate Cancer
- Transvesical Single Port Robotic Partial Prostatectomy
- High-intensity focused ultrasound (HIFU)
- (no location specified)
Nov 3, 2022
Benign Prostatic Hyperplasia Trial in Bordeaux (Partial surgery preserving the prostatic apex, Conventional endoscopic prostatic
Recruiting
- Benign Prostatic Hyperplasia
- Partial surgery preserving the prostatic apex
- Conventional endoscopic prostatic surgery
-
Bordeaux, FranceCentre Hospitalier Universitaire de Bordeaux
Nov 16, 2022
Recurrent Prostate Cancer Trial in Kelowna (HDR partial prostate brachytherapy)
Recruiting
- Recurrent Prostate Cancer
- HDR partial prostate brachytherapy
-
Kelowna, British Columbia, CanadaBCCA Center for the Southern Interior
Jun 29, 2021
Prostate Cancer Trial in Candiolo (Robotic hemi-prostatectomy with urethral preservation)
Recruiting
- Prostate Cancer
- Robotic hemi-prostatectomy with urethral preservation
-
Candiolo, TO, ItalyFondazione del Piemonte per l'Oncologia
Apr 16, 2023
Prostate Cancer, Adverse Effects Surgery, MRI Trial in Hialeah (TRANBERG® Transperineal Fusion Laser--Induced Thermal Therapy of
Recruiting
- Prostate Cancer
- +8 more
- TRANBERG® Transperineal Fusion Laser--Induced Thermal Therapy of Prostate Cancer (TPF-LITT)
-
Hialeah, FloridaUrology Specialist Group
Jan 24, 2023
Prostate Cancer Metastatic Trial in Spain (Olaparib)
Active, not recruiting
- Prostate Cancer Metastatic
-
Santiago De Compostela, A Coruña, Spain
- +7 more
Feb 8, 2022
Kidney Cancer, Prostate Cancer Trial in Columbia (Lidocaine Hydrochloride 0.8% in Dextrose 5% Solution, 0.9% Sodium Chloride
Recruiting
- Kidney Cancer
- Prostate Cancer
- Lidocaine Hydrochloride 0.8% in Dextrose 5% Solution
- 0.9% Sodium Chloride Injection
-
Columbia, MissouriUniversity Hospital
Jan 21, 2022
Gather More Information About Bone Fractures and Survival in
Completed
- Metastatic Castration-Resistant Prostate Cancer
- Radium-223 dichloride (Xofigo, BAY88-8223)
- Other standard care
-
Database Study, SwedenDatabase Study
Jul 1, 2021
Localized Prostate Cancer Trial in New York (TOOKAD®)
Withdrawn
- Localized Prostate Cancer
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Nov 10, 2020
Prostate Cancer Trial in Poznan (brachytherapy)
Recruiting
- Prostate Cancer
- brachytherapy
-
Poznań, Greater Poland, PolandGreater Poland Cancer Centre / Brachytherapy Department
Jan 27, 2023
Prostate Cancer Trial in Kyoto (The Visual Ice Cryoablation System)
Recruiting
- Prostate Cancer
- The Visual Ice Cryoablation System
-
Kyoto, Japan
- +1 more
Aug 13, 2022
Prostate Cancer, Localized Prostate Carcinoma Trial (PSMA-1007 Positron Emission Tomography (PET) scan)
Not yet recruiting
- Prostate Cancer
- Localized Prostate Carcinoma
- PSMA-1007 Positron Emission Tomography (PET) scan
- (no location specified)
Aug 14, 2023
Metastatic Hormone Sensitive Prostate Cancer Treated With
Not yet recruiting
- Metastatic Hormone-sensitive Prostate Cancer
-
Innsbruck, Austria
- +42 more
Jun 5, 2023
Prostate Cancer Trial (Lutetium Lu 177 JH020002 Injection)
Not yet recruiting
- Prostate Cancer
- Lutetium Lu 177 JH020002 Injection
- (no location specified)
Nov 14, 2023
Prostate Adenocarcinoma Trial in Madrid (Prostate SBRT (stereotactic body radiation therapy) with focal boost)
Not yet recruiting
- Prostate Adenocarcinoma
- Prostate SBRT (stereotactic body radiation therapy) with focal boost
-
Madrid, SpainLa Princesa University Hospital, Health Research Institute, Madr
Jun 16, 2023
Prostate Cancer Trial in Baltimore (DFMO, testosterone cypionate, Luteinizing hormone-releasing hormone (LHRH) analogue)
Not yet recruiting
- Prostate Cancer
- DFMO
- +3 more
-
Baltimore, MarylandJohns Hopkins University: Sidney Kimmel Comprehensive Cancer Cen
Sep 22, 2023
Prostatic Tumors, Metastatic Castration-Resistant Prostate Cancer Trial (MK-5684, Dexamethasone, Fludrocortisone acetate)
Not yet recruiting
- Prostatic Neoplasms
- Metastatic Castration-Resistant Prostate Cancer
- MK-5684
- +3 more
- (no location specified)
Oct 23, 2023
Prostate Cancer Trial in Beijing, Shanghai (Phase I:[177Lu]Lu-XT033 Injection, Phase II:[177Lu]Lu-XT033 Injection)
Not yet recruiting
- Prostate Cancer
- Phase I:[177Lu]Lu-XT033 Injection
- Phase II:[177Lu]Lu-XT033 Injection
-
Beijing, Beijing, China
- +1 more
Oct 7, 2023
Prostate Cancer Trial in Roma (Soractelite Echolaser Transperineal focal laser ablation)
Recruiting
- Prostate Cancer
- Soractelite Echolaser Transperineal focal laser ablation
-
Roma, RM, ItalySan Carlo di Nancy Hospital
Oct 16, 2022
Prostate Cancer Trial in Los Angeles (high resolution MRI (hrMRI))
Completed
- Prostate Cancer
- high resolution MRI (hrMRI)
-
Los Angeles, CaliforniaCedars Sinai Medical Center
Dec 14, 2022
Metastatic Castration Resistant Prostate Cancer, Metastatic Cancer, Solid Tumor Trial in United States (Nivolumab, Ipilimumab)
Active, not recruiting
- Metastatic Castration Resistant Prostate Cancer
- +2 more
-
San Diego, California
- +7 more
Jan 23, 2023
Bladder Cancer, Prostate Cancer, Renal Cancer Trial in Qingdao (robot-assisted surgery)
Not yet recruiting
- Bladder Cancer
- +2 more
- robot-assisted surgery
-
Qingdao, Shandong, ChinaThe Affiliated Hospital of Qingdao University
Jul 20, 2022
Advanced Prostate Cancer Trial in Lyon, Villejuif, Rotterdam (JNJ-78278343, JNJ-87189401)
Not yet recruiting
- Advanced Prostate Cancer
-
Lyon, France
- +2 more
Oct 18, 2023